Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 8 | 2024 | 2325 | 1.410 |
Why?
|
Sepsis | 18 | 2015 | 2587 | 1.360 |
Why?
|
Myeloid Cells | 4 | 2014 | 820 | 0.950 |
Why?
|
End Stage Liver Disease | 2 | 2020 | 352 | 0.930 |
Why?
|
Splenorenal Shunt, Surgical | 1 | 2022 | 14 | 0.820 |
Why?
|
Choledochal Cyst | 1 | 2022 | 25 | 0.800 |
Why?
|
Pancreas Transplantation | 2 | 2022 | 196 | 0.790 |
Why?
|
Alagille Syndrome | 1 | 2021 | 45 | 0.770 |
Why?
|
Hypertension, Renovascular | 1 | 2021 | 116 | 0.760 |
Why?
|
Gallbladder | 1 | 2022 | 305 | 0.710 |
Why?
|
Immunity, Innate | 10 | 2015 | 3047 | 0.680 |
Why?
|
Esophageal and Gastric Varices | 1 | 2022 | 208 | 0.680 |
Why?
|
Hypertension, Portal | 1 | 2022 | 226 | 0.670 |
Why?
|
Hematoma, Subdural | 1 | 2020 | 127 | 0.640 |
Why?
|
Wounds and Injuries | 7 | 2013 | 2476 | 0.590 |
Why?
|
Myelopoiesis | 3 | 2015 | 134 | 0.580 |
Why?
|
Chemokine CXCL10 | 4 | 2014 | 316 | 0.550 |
Why?
|
Adaptor Proteins, Vesicular Transport | 3 | 2014 | 306 | 0.550 |
Why?
|
Bacterial Infections | 3 | 2013 | 1401 | 0.490 |
Why?
|
Meconium | 2 | 2012 | 47 | 0.480 |
Why?
|
Immune Tolerance | 7 | 2014 | 2297 | 0.480 |
Why?
|
Enema | 2 | 2012 | 141 | 0.470 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2020 | 800 | 0.440 |
Why?
|
Cecum | 5 | 2014 | 232 | 0.440 |
Why?
|
Toll-Like Receptors | 2 | 2014 | 590 | 0.420 |
Why?
|
Leukocytes | 9 | 2014 | 2025 | 0.420 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2014 | 237 | 0.420 |
Why?
|
Wounds, Nonpenetrating | 6 | 2015 | 793 | 0.420 |
Why?
|
Suppressor Factors, Immunologic | 1 | 2012 | 68 | 0.410 |
Why?
|
Cachexia | 1 | 2014 | 197 | 0.410 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1292 | 0.410 |
Why?
|
Ileal Diseases | 1 | 2012 | 69 | 0.390 |
Why?
|
Barium Sulfate | 1 | 2012 | 180 | 0.390 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2011 | 45 | 0.370 |
Why?
|
Fundoplication | 1 | 2011 | 144 | 0.350 |
Why?
|
Receptors, CXCR3 | 1 | 2011 | 238 | 0.350 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1228 | 0.320 |
Why?
|
Waiting Lists | 2 | 2024 | 762 | 0.310 |
Why?
|
Trauma Centers | 2 | 2014 | 933 | 0.310 |
Why?
|
Gastrostomy | 1 | 2011 | 321 | 0.310 |
Why?
|
Myeloproliferative Disorders | 1 | 2014 | 606 | 0.300 |
Why?
|
Intestinal Obstruction | 1 | 2012 | 433 | 0.300 |
Why?
|
Horses | 1 | 2009 | 298 | 0.300 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2008 | 30 | 0.300 |
Why?
|
Thrombosis | 1 | 2022 | 2929 | 0.300 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4312 | 0.290 |
Why?
|
Pancreas | 2 | 2012 | 1676 | 0.280 |
Why?
|
Animals, Newborn | 5 | 2015 | 2672 | 0.270 |
Why?
|
Signal Transduction | 9 | 2014 | 23342 | 0.260 |
Why?
|
Cause of Death | 2 | 2013 | 3675 | 0.250 |
Why?
|
Cystic Fibrosis | 3 | 2012 | 1274 | 0.250 |
Why?
|
Cytokines | 8 | 2014 | 7338 | 0.250 |
Why?
|
Hematopoietic Stem Cells | 3 | 2015 | 3384 | 0.250 |
Why?
|
Gastroesophageal Reflux | 1 | 2011 | 816 | 0.220 |
Why?
|
Clonal Anergy | 1 | 2003 | 171 | 0.220 |
Why?
|
Hepatoblastoma | 1 | 2023 | 88 | 0.220 |
Why?
|
Preoperative Care | 2 | 2011 | 2249 | 0.210 |
Why?
|
Mice | 26 | 2023 | 81101 | 0.210 |
Why?
|
Lymphocyte Activation | 3 | 2010 | 5490 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2015 | 18119 | 0.200 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 2022 | 39 | 0.200 |
Why?
|
Phagocytosis | 5 | 2015 | 1533 | 0.200 |
Why?
|
Child | 13 | 2024 | 79818 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2013 | 4353 | 0.190 |
Why?
|
Shock, Hemorrhagic | 2 | 2013 | 223 | 0.190 |
Why?
|
Granulocytes | 2 | 2014 | 550 | 0.190 |
Why?
|
Nanotechnology | 1 | 2006 | 707 | 0.180 |
Why?
|
Neutrophils | 7 | 2015 | 3765 | 0.180 |
Why?
|
APACHE | 4 | 2013 | 267 | 0.180 |
Why?
|
Melanoma, Experimental | 1 | 2003 | 559 | 0.180 |
Why?
|
Genomics | 2 | 2013 | 5790 | 0.180 |
Why?
|
BK Virus | 1 | 2020 | 123 | 0.170 |
Why?
|
Animals | 29 | 2023 | 167768 | 0.160 |
Why?
|
Portal Vein | 1 | 2022 | 429 | 0.160 |
Why?
|
Erythrocyte Transfusion | 2 | 2015 | 563 | 0.160 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2022 | 506 | 0.160 |
Why?
|
Gastric Mucosa | 1 | 2022 | 600 | 0.160 |
Why?
|
Athletic Injuries | 1 | 2009 | 1211 | 0.160 |
Why?
|
Mice, Knockout | 8 | 2015 | 14354 | 0.160 |
Why?
|
Interferon Type I | 2 | 2014 | 559 | 0.160 |
Why?
|
Antigens, Neoplasm | 2 | 2003 | 1997 | 0.160 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 194 | 0.150 |
Why?
|
Mice, Inbred C57BL | 13 | 2023 | 22003 | 0.150 |
Why?
|
Humans | 45 | 2024 | 758406 | 0.150 |
Why?
|
Neutrophil Infiltration | 2 | 2011 | 390 | 0.150 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1097 | 0.150 |
Why?
|
Tumor Virus Infections | 1 | 2020 | 438 | 0.140 |
Why?
|
Kidney Transplantation | 2 | 2024 | 4217 | 0.140 |
Why?
|
Macrophages, Peritoneal | 2 | 2015 | 237 | 0.140 |
Why?
|
Clostridium Infections | 2 | 2015 | 557 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 2 | 2011 | 577 | 0.140 |
Why?
|
Ligation | 4 | 2010 | 448 | 0.130 |
Why?
|
Tissue and Organ Procurement | 1 | 2024 | 943 | 0.130 |
Why?
|
Injury Severity Score | 3 | 2014 | 1033 | 0.130 |
Why?
|
Abdomen | 1 | 2022 | 1129 | 0.130 |
Why?
|
Multiple Organ Failure | 3 | 2012 | 385 | 0.130 |
Why?
|
Tissue Donors | 2 | 2022 | 2311 | 0.130 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1230 | 0.120 |
Why?
|
Mice, Inbred BALB C | 5 | 2014 | 6209 | 0.120 |
Why?
|
Male | 30 | 2024 | 358747 | 0.120 |
Why?
|
Child, Preschool | 6 | 2024 | 42062 | 0.120 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12604 | 0.120 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1110 | 0.120 |
Why?
|
Reoperation | 2 | 2024 | 4282 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4549 | 0.120 |
Why?
|
Caspase 1 | 1 | 2015 | 226 | 0.120 |
Why?
|
Monocytes | 1 | 2023 | 2570 | 0.110 |
Why?
|
Lung Diseases | 1 | 2024 | 1910 | 0.110 |
Why?
|
Chemokines | 2 | 2014 | 961 | 0.110 |
Why?
|
Omentum | 1 | 2014 | 169 | 0.110 |
Why?
|
Muscle Neoplasms | 1 | 2014 | 133 | 0.110 |
Why?
|
Gene Expression Regulation | 5 | 2014 | 11892 | 0.110 |
Why?
|
Female | 26 | 2024 | 390323 | 0.110 |
Why?
|
Living Donors | 1 | 2017 | 638 | 0.100 |
Why?
|
Burns | 3 | 2013 | 1848 | 0.100 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2014 | 581 | 0.100 |
Why?
|
Punctures | 2 | 2010 | 365 | 0.100 |
Why?
|
Transplantation, Homologous | 2 | 2020 | 4809 | 0.100 |
Why?
|
Sacrum | 1 | 2014 | 277 | 0.100 |
Why?
|
Lactoferrin | 1 | 2013 | 100 | 0.100 |
Why?
|
Syndrome | 2 | 2024 | 3262 | 0.100 |
Why?
|
Micelles | 1 | 2012 | 192 | 0.100 |
Why?
|
Caspases | 1 | 2015 | 876 | 0.100 |
Why?
|
Soybean Oil | 1 | 2012 | 139 | 0.100 |
Why?
|
Calcitonin | 1 | 2013 | 330 | 0.100 |
Why?
|
Plasma | 1 | 2015 | 584 | 0.100 |
Why?
|
Florida | 2 | 2013 | 431 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1031 | 0.100 |
Why?
|
Inflammation | 5 | 2015 | 10718 | 0.100 |
Why?
|
Inflammasomes | 2 | 2015 | 527 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2292 | 0.090 |
Why?
|
Critical Care | 2 | 2015 | 2692 | 0.090 |
Why?
|
Retrospective Studies | 11 | 2024 | 80168 | 0.090 |
Why?
|
Acute Kidney Injury | 2 | 2013 | 1926 | 0.090 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2013 | 354 | 0.090 |
Why?
|
Surgical Procedures, Operative | 2 | 2012 | 1911 | 0.090 |
Why?
|
Wound Infection | 1 | 2013 | 243 | 0.090 |
Why?
|
Hospital Mortality | 3 | 2013 | 5272 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2013 | 369 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4158 | 0.090 |
Why?
|
Hirschsprung Disease | 1 | 2012 | 163 | 0.090 |
Why?
|
Reactive Oxygen Species | 2 | 2014 | 2129 | 0.090 |
Why?
|
Ileus | 1 | 2009 | 57 | 0.080 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2012 | 314 | 0.080 |
Why?
|
Infant, Newborn | 5 | 2014 | 26183 | 0.080 |
Why?
|
Kidney | 2 | 2023 | 7016 | 0.080 |
Why?
|
Hepatitis C | 1 | 2020 | 1579 | 0.080 |
Why?
|
Bone Marrow Cells | 4 | 2011 | 2414 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1028 | 0.080 |
Why?
|
Lectins, C-Type | 1 | 2013 | 585 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2011 | 748 | 0.080 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 454 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2024 | 15637 | 0.080 |
Why?
|
Protein Precursors | 1 | 2013 | 1133 | 0.080 |
Why?
|
Gastric Emptying | 1 | 2011 | 242 | 0.080 |
Why?
|
Protective Clothing | 1 | 2009 | 103 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2003 | 3217 | 0.080 |
Why?
|
Peritonitis | 1 | 2010 | 369 | 0.080 |
Why?
|
Models, Immunological | 1 | 2010 | 513 | 0.080 |
Why?
|
Cell Proliferation | 3 | 2014 | 10416 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 855 | 0.080 |
Why?
|
Survival Analysis | 4 | 2014 | 10112 | 0.080 |
Why?
|
Immunity | 1 | 2014 | 998 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1788 | 0.070 |
Why?
|
Acute Lung Injury | 1 | 2011 | 367 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4313 | 0.070 |
Why?
|
Unnecessary Procedures | 1 | 2011 | 411 | 0.070 |
Why?
|
Blood Proteins | 1 | 2013 | 1173 | 0.070 |
Why?
|
Antigen-Presenting Cells | 4 | 2005 | 964 | 0.070 |
Why?
|
Lymphoma, B-Cell | 2 | 2005 | 935 | 0.070 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.070 |
Why?
|
Infant | 3 | 2024 | 36055 | 0.070 |
Why?
|
Cross Infection | 2 | 2013 | 1432 | 0.070 |
Why?
|
Virus Diseases | 1 | 2013 | 719 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5404 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2497 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2011 | 5864 | 0.070 |
Why?
|
Nanotubes, Carbon | 1 | 2006 | 71 | 0.060 |
Why?
|
Interleukin-6 | 2 | 2013 | 3208 | 0.060 |
Why?
|
Benchmarking | 1 | 2012 | 1042 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1600 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4244 | 0.060 |
Why?
|
Brain Injuries | 2 | 2015 | 2044 | 0.060 |
Why?
|
Graft Rejection | 3 | 2024 | 4426 | 0.060 |
Why?
|
Artifacts | 1 | 2013 | 1897 | 0.060 |
Why?
|
Liver Diseases | 1 | 2013 | 1296 | 0.060 |
Why?
|
Mice, SCID | 3 | 2005 | 2626 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2014 | 18940 | 0.060 |
Why?
|
Bacteremia | 1 | 2010 | 980 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2014 | 17768 | 0.050 |
Why?
|
Primary Graft Dysfunction | 1 | 2024 | 111 | 0.050 |
Why?
|
Graft Survival | 2 | 2024 | 3794 | 0.050 |
Why?
|
Time Factors | 5 | 2023 | 39872 | 0.050 |
Why?
|
Adaptive Immunity | 3 | 2014 | 726 | 0.050 |
Why?
|
Escherichia coli | 1 | 2014 | 4215 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2023 | 622 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2023 | 64378 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2531 | 0.050 |
Why?
|
Ischemia | 1 | 2010 | 1863 | 0.050 |
Why?
|
Nanostructures | 1 | 2006 | 547 | 0.050 |
Why?
|
Oxygen | 1 | 2012 | 4191 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14641 | 0.050 |
Why?
|
Adolescent | 6 | 2024 | 87892 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 3997 | 0.050 |
Why?
|
Antigen Presentation | 2 | 2003 | 1254 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2014 | 3774 | 0.050 |
Why?
|
Accidental Falls | 1 | 2009 | 1056 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2013 | 2040 | 0.050 |
Why?
|
Trauma Severity Indices | 2 | 2013 | 478 | 0.050 |
Why?
|
Receptor, Interferon alpha-beta | 2 | 2011 | 112 | 0.040 |
Why?
|
Neoplasms | 2 | 2006 | 22032 | 0.040 |
Why?
|
Macrophages | 3 | 2011 | 5737 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7583 | 0.040 |
Why?
|
Mice, Inbred C3H | 2 | 2011 | 915 | 0.040 |
Why?
|
Middle Aged | 8 | 2020 | 219568 | 0.040 |
Why?
|
Postoperative Period | 1 | 2023 | 1812 | 0.040 |
Why?
|
Genome, Human | 1 | 2011 | 4416 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2011 | 9518 | 0.040 |
Why?
|
Adult | 12 | 2024 | 219935 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12759 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2011 | 4738 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7590 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16886 | 0.040 |
Why?
|
Gene Expression Profiling | 4 | 2014 | 9404 | 0.040 |
Why?
|
Spleen | 2 | 2013 | 2296 | 0.040 |
Why?
|
Incidence | 2 | 2013 | 21272 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3521 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15225 | 0.030 |
Why?
|
Young Adult | 5 | 2015 | 58808 | 0.030 |
Why?
|
Length of Stay | 3 | 2023 | 6439 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4458 | 0.030 |
Why?
|
Prognosis | 4 | 2024 | 29557 | 0.030 |
Why?
|
Pancreaticojejunostomy | 1 | 1995 | 26 | 0.030 |
Why?
|
Caspases, Initiator | 1 | 2015 | 31 | 0.030 |
Why?
|
Lymphoma | 1 | 2004 | 1896 | 0.030 |
Why?
|
Critical Illness | 3 | 2012 | 2703 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20055 | 0.030 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1995 | 120 | 0.030 |
Why?
|
Risk Assessment | 2 | 2013 | 23884 | 0.030 |
Why?
|
Buttocks | 1 | 2014 | 111 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2014 | 6234 | 0.030 |
Why?
|
Piperazines | 1 | 2004 | 2511 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2003 | 1454 | 0.030 |
Why?
|
Trans-Activators | 1 | 2003 | 2860 | 0.030 |
Why?
|
Hematocrit | 1 | 2015 | 627 | 0.030 |
Why?
|
Cohort Studies | 2 | 2013 | 41256 | 0.030 |
Why?
|
Peritoneum | 1 | 2014 | 224 | 0.030 |
Why?
|
Hepacivirus | 1 | 2020 | 1333 | 0.030 |
Why?
|
Pyrimidines | 1 | 2004 | 3006 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2003 | 3485 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 1 | 2011 | 299 | 0.020 |
Why?
|
Pancreaticoduodenectomy | 1 | 1995 | 508 | 0.020 |
Why?
|
Endotoxemia | 1 | 2013 | 196 | 0.020 |
Why?
|
Acute Disease | 2 | 2013 | 7225 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2011 | 328 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 2013 | 928 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2013 | 314 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2013 | 655 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 372 | 0.020 |
Why?
|
Receptors, Pattern Recognition | 1 | 2011 | 83 | 0.020 |
Why?
|
Immune System Diseases | 1 | 2012 | 258 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1651 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1593 | 0.020 |
Why?
|
Diatrizoate Meglumine | 1 | 2009 | 79 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 468 | 0.020 |
Why?
|
Listeriosis | 1 | 2010 | 148 | 0.020 |
Why?
|
Disease Progression | 2 | 2024 | 13468 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12870 | 0.020 |
Why?
|
Endotoxins | 1 | 2011 | 521 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2010 | 261 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 812 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10171 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8175 | 0.020 |
Why?
|
Long-Term Care | 1 | 2012 | 631 | 0.020 |
Why?
|
Pneumonia, Bacterial | 1 | 2010 | 318 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3056 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1759 | 0.020 |
Why?
|
Age Factors | 2 | 2014 | 18358 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2697 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2904 | 0.020 |
Why?
|
Pseudomonas Infections | 1 | 2010 | 621 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9574 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11471 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 1444 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1878 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 22029 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2011 | 803 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4113 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39059 | 0.010 |
Why?
|
Tyrphostins | 1 | 2003 | 63 | 0.010 |
Why?
|
Radiography | 2 | 2009 | 6954 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2012 | 2131 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2005 | 602 | 0.010 |
Why?
|
Ovalbumin | 1 | 2004 | 673 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2204 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2015 | 4938 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2413 | 0.010 |
Why?
|
Hemagglutinins, Viral | 1 | 2001 | 66 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12096 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13591 | 0.010 |
Why?
|
RNA | 1 | 2011 | 2716 | 0.010 |
Why?
|
Birth Weight | 1 | 2009 | 2097 | 0.010 |
Why?
|
United States | 2 | 2024 | 72136 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2010 | 1406 | 0.010 |
Why?
|
Gestational Age | 1 | 2009 | 3565 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2010 | 2047 | 0.010 |
Why?
|
Bone Marrow | 1 | 2010 | 2909 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58683 | 0.010 |
Why?
|
Proteomics | 1 | 2013 | 3816 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2003 | 868 | 0.010 |
Why?
|
Benzamides | 1 | 2004 | 1368 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2001 | 595 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2012 | 3732 | 0.010 |
Why?
|
Aged | 4 | 2015 | 168218 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12945 | 0.010 |
Why?
|
Clone Cells | 1 | 2001 | 1660 | 0.010 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1998 | 173 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2001 | 2013 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1995 | 5349 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15785 | 0.010 |
Why?
|
Blood Pressure | 1 | 2012 | 8451 | 0.010 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 1998 | 172 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 73809 | 0.010 |
Why?
|
Ampulla of Vater | 1 | 1995 | 149 | 0.010 |
Why?
|
Body Mass Index | 1 | 2012 | 12876 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6127 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2001 | 2693 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2004 | 2723 | 0.010 |
Why?
|
Pancreatic Ducts | 1 | 1995 | 329 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3709 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13447 | 0.010 |
Why?
|
Prospective Studies | 2 | 2013 | 54137 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5098 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17617 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 1995 | 983 | 0.010 |
Why?
|
Models, Biological | 1 | 2001 | 9460 | 0.000 |
Why?
|
Survival Rate | 1 | 1995 | 12721 | 0.000 |
Why?
|